These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1697375)

  • 1. Comparability of the electrophysiologic responses and plasma and myocardial tissue concentrations of sotalol and its d stereoisomer in the dog.
    Gomoll AW; Lekich RF; Bartek MJ; Comereski CR; Antonaccio MJ
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):204-11. PubMed ID: 1697375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative beta-blocking activities and electrophysiologic actions of racemic sotalol and its optical isomers in anesthetized dogs.
    Gomoll AW; Bartek MJ
    Eur J Pharmacol; 1986 Dec; 132(2-3):123-35. PubMed ID: 2880732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac electrophysiologic and inotropic actions of new and potent methanesulfonanilide class III antiarrhythmic agents in anesthetized dogs.
    Wallace AA; Stupienski RF; Brookes LM; Selnick HG; Claremon DA; Lynch JJ
    J Cardiovasc Pharmacol; 1991 Nov; 18(5):687-95. PubMed ID: 1723765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiologic and hemodynamic effects of H 234/09 (almokalant), quinidine, and (+)-sotalol in the anesthetized dog.
    Duker G; Almgren O; Carlsson L
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):458-65. PubMed ID: 1279293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic effects of sotalol on the immature mammalian heart.
    Houyel L; Fournier A; Ducharme G; Chartrand C; Davignon A
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):134-9. PubMed ID: 1375680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of WAY-123,398, a new class III antiarrhythmic agent, on cardiac refractoriness and ventricular fibrillation threshold in anesthetized dogs: a comparison with UK-68798, E-4031, and dl-sotalol.
    Spinelli W; Parsons RW; Colatsky TJ
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):913-22. PubMed ID: 1282594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intravenous azimilide on cardiac performance, fibrillation threshold, and hemodynamics in anesthetized dogs.
    Brooks RR; Finch SL
    Arzneimittelforschung; 2000 Jul; 50(7):597-605. PubMed ID: 10965415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma level and action of sotalol-HCL on the ECG interval after parenteral administration in healthy subjects].
    Rehm KD; Schnelle K; Dyde CJ; Blümner E; Arendts W
    Arzneimittelforschung; 1987 Sep; 37(9):1058-62. PubMed ID: 3435602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humans.
    Funck-Brentano C; Kibleur Y; Le Coz F; Poirier JM; Mallet A; Jaillon P
    Circulation; 1991 Feb; 83(2):536-45. PubMed ID: 1846784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic, electrocardiographic, electrophysiologic and pharmacokinetic activity of 4'-hydroxypropranolol in dogs.
    Muir WW; Sams RA; Schall SF
    J Vet Pharmacol Ther; 1996 Aug; 19(4):259-67. PubMed ID: 8866453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic effects of d-sotalol in humans.
    McComb JM; McGovern B; McGowan JB; Ruskin JN; Garan H
    J Am Coll Cardiol; 1987 Jul; 10(1):211-7. PubMed ID: 3597990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sotalol controlled-release systems for arrhythmias: in vitro characterization, in vivo drug disposition, and electrophysiologic effects.
    Labhasetwar V; Underwood T; Gallagher M; Murphy G; Langberg J; Levy RJ
    J Pharm Sci; 1994 Feb; 83(2):156-64. PubMed ID: 8169781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic effect of a sotalol-mexiletine combination on induced ventricular tachycardia in dogs.
    Chézalviel F; Weissenburger J; Guhennec C; Jagueux M; Davy JM; Vernhet L; Simandoux V; Poirier JM; Cheymol G
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):212-20. PubMed ID: 7679154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term stability, reproducibility, and statistical sensitivity of a telemetry-instrumented dog model: A 27-month longitudinal assessment.
    Fryer RM; Ng KJ; Chi L; Jin X; Reinhart GA
    J Pharmacol Toxicol Methods; 2015; 74():26-32. PubMed ID: 25946685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological effects of MS-551, a new class III agent: comparison with dl-sotalol in dogs.
    Sen L; Cui G; Sakaguchi Y; Singh BN
    J Pharmacol Exp Ther; 1998 May; 285(2):687-94. PubMed ID: 9580614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the cardiovascular effects of (+)-sotalol and (+/-)-sotalol following intravenous administration in normal volunteers.
    Johnston GD; Finch MB; McNeill JA; Shanks RG
    Br J Clin Pharmacol; 1985 Nov; 20(5):507-10. PubMed ID: 4074623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol.
    Weissenburger J; Davy JM; Chézalviel F; Ertzbischoff O; Poirier JM; Engel F; Lainée P; Penin E; Motté G; Cheymol G
    J Pharmacol Exp Ther; 1991 Nov; 259(2):871-83. PubMed ID: 1941633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term myocardial uptake of d- and l-sotalol in humans: relation to hemodynamic and electrophysiologic effects.
    Ritchie RH; Sallustio BC; Hii JT; Horowitz JD
    J Cardiovasc Pharmacol; 1998 Jun; 31(6):876-84. PubMed ID: 9641472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Electrophysiological effects of intravenous sotalol. Relation with plasma levels].
    Dumoulin P; Weissenburger J; Poirier JM; Rosensztajn L; Gallet B; Jaillon P; Têtard C; Cheymol G; Valty J
    Arch Mal Coeur Vaiss; 1985 Apr; 78(4):562-8. PubMed ID: 3923983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction.
    Feld GK; Venkatesh N; Singh BN
    Circulation; 1986 Jul; 74(1):197-204. PubMed ID: 3708774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.